NCT06597526View on ClinicalTrials.gov

The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

March 31, 2028

Study Completion Date

May 31, 2029

Conditions
Peritoneal MetastasisGastric Cancer
Trial Locations (1)

200025

RECRUITING

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER